AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Quest Diagnostics (DGX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

169.83

1.06 (0.63%)

At close: Feb 18, 2025, 3:59 PM

169.65

-0.11%

After-hours: Feb 18, 2025, 04:11 PM EST

undefined% (undefined)

Bid	165.77
Market Cap	18.96B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	7.7
PE Ratio (ttm)	22.06
Forward PE	n/a
Analyst	Hold

Ask	185
Volume	640,569
Avg. Volume (20D)	900,628
Open	168.09
Previous Close	168.77
Day's Range	166.46 - 170.16
52-Week Range	123.30 - 171.30
Beta	undefined

About DGX

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPat...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Dec 17, 1996

Employees 55,000

Stock Exchange NYSE

Ticker Symbol DGX

Website https://www.questdiagnostics.com

Full Company Profile

Analyst Forecast

According to 13 analyst ratings, the average rating for DGX stock is "Hold." The 12-month stock price forecast is $180, which is an increase of 5.99% from the latest price.

Buy 53.85%

Hold 46.15%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Quest Diagnostics is scheduled to release its earnings on Apr 22, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 weeks ago

+5.62%

Quest Diagnostics shares are trading higher follow... Unlock content with Pro Subscription

3 months ago

+6.85%

Quest Diagnostics shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 revenue guidance above estimates.

News

1 week ago · zacks.com

Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

1 week ago · zacks.com

Quest Diagnostics Stock to Gain From Innovation Amid Industry Threats

Within brain health, the robust demand for AD-detect blood tests for assessing Alzheimer's disease risk drives solid growth for DGX in the fourth quarter of 2024.

2 weeks ago · zacks.com

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

2 weeks ago · zacks.com

Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

2 weeks ago · zacks.com

Quest Diagnostics (DGX) is a Great Momentum Stock: Should You Buy?

Does Quest Diagnostics (DGX) have what it takes to be a top stock pick for momentum investors? Let's find out.

2 weeks ago · fool.com

Why Quest Diagnostics Stock Was Blasting Higher Today

Quest Diagnostics (DGX 5.49%) stock was teasing its all-time high on Thursday, no mean feat for a company that's been publicly traded for decades. The healthcare testing specialist's share price was u...

2 weeks ago · seekingalpha.com

Quest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call Transcript

Quest Diagnostics Incorporated (NYSE:DGX ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Jim Davis - President & CEO Sam Samad - EVP & CFO Shawn Bevec - VP, IR Conf...

2 weeks ago · fool.com

Quest Diagnostics EPS Tops Predictions

Quest Diagnostics (DGX 6.36%), a leader in diagnostic testing and information services, released its fourth quarter results on Jan. 30. The company reported a notable quarter with adjusted earnings pe...

2 weeks ago · zacks.com

DGX Stock Dips Despite Q4 Earnings and Revenue Beat, Margins Rise

Quest Diagnostics' fourth-quarter 2024 performance benefits from the strength of its core business.

2 weeks ago · zacks.com

Quest Diagnostics (DGX) Q4 Earnings and Revenues Top Estimates

Quest Diagnostics (DGX) came out with quarterly earnings of $2.23 per share, beating the Zacks Consensus Estimate of $2.19 per share. This compares to earnings of $2.15 per share a year ago.

Load More News